A major goal of this research is to increase our understanding of the 26S proteasome, the ATP-dependent complex, which preferentially degrades ubiquitin-conjugated proteins and catalyzes most of the protein degradation in animal cells. Unlike conventional proteases, this enzyme and its simpler homologs in prokaryotes are large ATP-hydrolyzing complexes that degrade polypeptides processively to small peptide. Recently, we discovered that the different active sites of the core 20S proteasome are allosterically regulated by peptide substrates and thus appear to function in a cyclical manner during protein breakdown (the """"""""bite-chew model). In coming years, we hope to elucidate the structural basis for these allosteric effects to determine whether the proteasome digests proteins in a preferred direction and to clarify how products are released by these particles. To understand the role of ATP hydrolysis, we are using as a model system the simpler proteasomes from archaea, where we recently discovered a proteasome ATPase complex, PAN, which homologous to the six ATPases in the 26S proteasome. We hope to clarify PAN's structure and how stimulates unfolding and translocation of substrates into the lumen of the 20S particle. Proteasomes degrade proteins to peptides that range from 3-22 residues. Most are quickly hydrolyzed in the cytosol to amino acids, but in mammals, some escape this fate and serve as precursors for the 8- to 9-residue peptides that are presented to the immune system on MHC-class I molecules. We have developed new methods to determine to what extent the 26S proteasomes and the alternative forms induced by gamma-interferon (immunoproteasomes and PA28-containing complexes) directly generate the antigenic peptides or yield larger precursors that are trimmed by aminopeptidases to the MHC-presented epitopes. We also hope to learn more about this trimming process and about the competing pathway by which most proteasome products are digested to amino acids.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM046147-09A1
Application #
6326571
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Jones, Warren
Project Start
1992-09-30
Project End
2005-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
9
Fiscal Year
2001
Total Cost
$474,463
Indirect Cost
Name
Harvard University
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Kisselev, Alexei F; van der Linden, Wouter A; Overkleeft, Herman S (2012) Proteasome inhibitors: an expanding army attacking a unique target. Chem Biol 19:99-115
Kisselev, Alexei F; Callard, Alice; Goldberg, Alfred L (2006) Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate. J Biol Chem 281:8582-90
Qiu, Xiao-Bo; Ouyang, Song-Ying; Li, Chao-Jun et al. (2006) hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37. EMBO J 25:5742-53
Lecker, Stewart H; Goldberg, Alfred L; Mitch, William E (2006) Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol 17:1807-19
Cascio, Paolo; Goldberg, Alfred L (2005) Preparation of hybrid (19S-20S-PA28) proteasome complexes and analysis of peptides generated during protein degradation. Methods Enzymol 398:336-52
Chang, Shih-Chung; Momburg, Frank; Bhutani, Nidhi et al. (2005) The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a ""molecular ruler"" mechanism. Proc Natl Acad Sci U S A 102:17107-12
Brignone, Chrystelle; Bradley, Kathleen E; Kisselev, Alexei F et al. (2004) A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway. Oncogene 23:4121-9
Kisselev, Alexei F; Garcia-Calvo, Margarita; Overkleeft, Herman S et al. (2003) The caspase-like sites of proteasomes, their substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sites. J Biol Chem 278:35869-77
Benaroudj, Nadia; Zwickl, Peter; Seemuller, Erika et al. (2003) ATP hydrolysis by the proteasome regulatory complex PAN serves multiple functions in protein degradation. Mol Cell 11:69-78
Huang, H C; Sherman, M Y; Kandror, O et al. (2001) The molecular chaperone DnaJ is required for the degradation of a soluble abnormal protein in Escherichia coli. J Biol Chem 276:3920-8

Showing the most recent 10 out of 28 publications